中国1型糖尿病诊治指南(2021版)

Guidelines for the diagnosis and treatment of type 1 diabetes mellitus in China(2021 edition)

近十年国内外1型糖尿病研究取得了重要进展,诊疗新方法和血糖监测等新技术不断问世,相关临床研究证据持续丰富。中华医学会糖尿病学分会、中国医师协会内分泌代谢科医师分会、中华医学会内分泌学分会和中华医学会儿科学分会,共同组织专家对2012版《中国1型糖尿病诊治指南》修订更新,形成了《中国1型糖尿病诊治指南(2021版)》。本指南共20章,内容涵盖中国1型糖尿病流行病学、诊断与分型、血糖监测、教育与管理、胰岛素治疗、医学营养治疗、运动治疗、胰腺与胰岛移植、低血糖防治、急慢性并发症、特殊时期临床管理、社会心理问题及对策、预测与预防等。本指南的发布将有助于进一步规范临床诊疗行为,促进行业水平提高和进步,改善患者生活质量与临床结局。

With the 10-year development and progress of science and technology,significant advances have been made in the field of type 1 diabetes from both domestic and international countries.The emergence of new technologies such as blood glucose monitoring,the evidence of clinical research has been accumulated and enriched.Therefore,the Chinese Diabetes Society,the Chinese Endocrinologist Association,the Chinese Society of Endocrinology,and the Chinese Pediatric Society,have jointly organized experts to update the 2012 edition of guideline for the diagnosis and treatment of type 1 diabetes mellitus in China,and to apply as much high-grade Chinese evidence as possible to develop the guideline for the diagnosis and treatment of type 1 diabetes mellitus in China(2021 edition).The new version guideline includes 20 chapters covering the epidemiology,diagnosis and classification,glucose monitoring,education and management,insulin therapy,medical nutrition therapy,exercise therapy,pancreas and islet transplantation,prevention and treatment of hypoglycemia,acute and chronic complications,clinical management in special stages,psychosocial issues and countermeasures of type 1 diabetes,as well as prediction and prevention.The promulgation of this guideline will help further standardize practical management for type 1 diabetes,and improve patients′quality of life and clinical outcomes.